Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical Trial
Crossref DOI link: https://doi.org/10.1007/s40262-016-0378-3
Published Online: 2016-03-07
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Krekels, Elke H. J.
Niebecker, Ronald
Karlsson, Mats O.
Miller, Raymond
Shimizu, Takako
Karlsson, Kristin E.
Ruff, Christian T.
Simonsson, Ulrika S. H.
Jönsson, Siv
Funding for this research was provided by:
Daiichi Sankyo Pharma Development
Text and Data Mining valid from 2016-03-07